<unk> , sold under the brand name Entadfi, is a fixed-dose combination medication used for the treatment of benign prostatic hyperplasia (BPH). It contains<unk>  and<unk> . It is taken by mouth. It was approved for medical use in the United States in December 2021.
Finasteride/tadalafil
Dutasteride/tamsulosin
Drospirenone/estetrol
Indacaterol/mometasone
Indacaterol/glycopyrronium bromide/mometasone
Dutasteride
Estradiol valerate/cyproterone acetate
Relugolix/estradiol/norethisterone acetate